相关实验视频

Updated: Jun 12, 2025

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

在进行广泛的胸壁切除术后,重建的新选择

João Paulo Cassiano de Macedo¹, Pedro Henrique Xavier Nabuco-de-Araujo², José Ribas M de Campos¹

¹Thoracic Surgery Department, Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.

Clinics (Sao Paulo, Brazil)

|May 16, 2025

概括

维塔格拉夫特 (Vitagraft®) 是一种合成骨移植替代品,在胸壁重建方面显示出有前途的生物相容性. 虽然28%的病例需要重新手术,但避免了重大并发症,这表明其潜在的安全性.

科学领域:

生物材料科学生物材料科学
手术创新在外科创新.
再生医学是一种再生医学.

背景情况:

胸壁重建对于切除后的结果至关重要.
胸壁重建的最佳材料仍然没有定义.
维塔格拉夫特 (Vitagraft®) 是一种合成,可吸收的骨诱导和骨导材料,由β-三酸陶 (β-TCP) 和聚乳糖酸聚合物 (PLGA) 组成.

研究的目的:

评估Vitagraft®在胸壁重建手术中的安全性和有效性.
评估与Vitagraft®在各种胸壁缺陷病因学中的使用相关的并发症和结果.

主要方法:

一项前性研究,涉及使用Vitagraft®进行胸壁重建的患者.
至少三个月的术后后续,监测变量包括KPS,ECOG,缺陷大小和并发症.
在八个病例中,Vitagraft®与网状组织一起使用,有各种迹象,包括瘤切除,胸裂,波兰综合征和胸裂变.

主要成果:

重建了八个胸壁切除瘤,一个是胸裂,一个是波兰综合征,一个是胸裂变.
在8名患者中,Vitagraft®与mesh一起用于重建.
两名患者 (28%) 需要重新手术,其中一人 (14%) 需要切除假肢;没有观察到呼吸衰竭或重大系统并发症.

结论:

在胸壁重建中,Vitagraft®表现出良好的生物相容性,这是术后断层扫描显示的.
虽然重新手术率为28%,假肢切除率为14%,但该材料似乎是安全的,避免了主要的系统性并发症.
需要进一步的研究来阐明骨化时间,特别是与缺陷大小相关,以优化其在胸壁重建中的使用.

关键词:

胸壁切除术胸壁切除术胸壁瘤在胸壁瘤.肌肉皮层的片重建重建的重建工作胸的瘤是一种瘤.切除脏的方法是切除脏.维塔格拉夫特®的使用方法

更多相关视频

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Surgical Fixation of Sternal Fractures: Preoperative Planning and a Safe Surgical Technique Using Locked Titanium Plates and Depth Limited Drilling

Surgical Fixation of Sternal Fractures: Preoperative Planning and a Safe Surgical Technique Using Locked Titanium Plates and Depth Limited Drilling

Published on: January 5, 2015

相关概念视频

Flail Chest-II

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Flail Chest-I

Flail Chest-I

Overview of Flail Chest
Flail chest is a severe and potentially life-threatening condition characterized by the fracture of three or more adjacent ribs in multiple places. It is most commonly caused by direct impacts and trauma, such as motor vehicle accidents or injuries from a steering wheel impact. It can also occur due to falls in elderly individuals with osteoporosis, or assaults involving sharp objects.
Pathophysiology
The pathophysiology of flail chest is complex, involving fractures of...